1
|
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
|
Science
|
2014
|
5.47
|
2
|
BAFF: a fundamental survival factor for B cells.
|
Nat Rev Immunol
|
2002
|
2.94
|
3
|
A lymphotoxin-driven pathway to hepatocellular carcinoma.
|
Cancer Cell
|
2009
|
2.64
|
4
|
Follicular dendritic cells emerge from ubiquitous perivascular precursors.
|
Cell
|
2012
|
2.50
|
5
|
TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
|
Neuron
|
2005
|
2.39
|
6
|
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
|
Blood
|
2011
|
2.33
|
7
|
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
|
Nat Rev Immunol
|
2003
|
2.10
|
8
|
Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis.
|
Gastroenterology
|
2012
|
1.43
|
9
|
Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells.
|
Nat Immunol
|
2012
|
1.40
|
10
|
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy.
|
J Clin Invest
|
2011
|
1.22
|
11
|
A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.
|
J Immunol
|
2003
|
1.09
|
12
|
Pillars article: A lymphotoxin-B-specific receptor. Science. 1994. 264: 707-710.
|
J Immunol
|
2014
|
1.06
|
13
|
Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
|
Arthritis Res Ther
|
2009
|
1.04
|
14
|
TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
|
J Biol Chem
|
2010
|
1.03
|
15
|
Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy.
|
Cancer Res
|
2006
|
1.01
|
16
|
A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
|
J Clin Invest
|
2003
|
0.99
|
17
|
Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway.
|
J Clin Invest
|
2002
|
0.97
|
18
|
Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
|
Arthritis Res Ther
|
2011
|
0.91
|
19
|
Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis.
|
J Clin Invest
|
2016
|
0.83
|
20
|
LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR.
|
Adv Exp Med Biol
|
2011
|
0.82
|
21
|
Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation.
|
Carcinogenesis
|
2013
|
0.80
|
22
|
Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis.
|
PLoS One
|
2013
|
0.79
|
23
|
Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury.
|
Neurol Res
|
2010
|
0.75
|
24
|
Workshop summary: control of lymphocyte function and repertoire by the TNF superfamily.
|
Adv Exp Med Biol
|
2011
|
0.75
|